Important Safety Information

×

Important Safety Information & Medical Disclaimer

1. Prescription-Only Medical Model

All treatments are strictly dispensed only against a valid prescription issued by a licensed medical practitioner. No product is supplied without doctor authorization. The platform operates as a doctor-led prescription facilitation system, not a self-medication service.

2. Doctor Oversight & Clinical Responsibility

* All treatment decisions are reviewed and finalized by registered dermatologists or licensed medical practitioners
* AI-based systems are used only for structured data collection (history, images, questionnaire) and do not diagnose or prescribe independently
* Patients may directly book consultation with a doctor through the platform for clinical evaluation

3. Active Pharmaceutical Ingredients – Safety Information

A. Minoxidil

* Used for androgenetic alopecia and hair regrowth support
* May cause scalp irritation, dryness, itching, or unwanted facial hair growth
* Rare systemic effects include dizziness or palpitations if overused or misused
* For external use only; avoid contact with eyes or broken skin

B. Finasteride

* Used for androgen-related hair loss in adult males only
* Strictly contraindicated in women and children
* Not allowed during pregnancy or in women planning pregnancy due to risk of fetal harm
* Possible side effects include sexual dysfunction, mood changes, and hormonal imbalance
* Must be used only under medical supervision

C. Dutasteride

* More potent 5-alpha reductase inhibitor used in selected cases of hair loss
* Not approved for use in women or minors
* Contraindicated in pregnancy due to risk of fetal abnormalities
* May cause hormonal and sexual side effects similar to finasteride, potentially longer lasting
* Requires strict physician monitoring and prescription control

D. Tretinoin

* Used as a topical retinoid for skin and scalp support and absorption enhancement
* May cause redness, peeling, irritation, and photosensitivity
* Must be used in controlled concentrations under medical guidance
* Avoid excessive sun exposure during use

4. Age & Use Restrictions

* All prescription treatments are strictly for 18 years and above
* Pediatric use is not permitted
* Women must avoid anti-androgen medications like Finasteride and Dutasteride
* Special caution is required in pregnancy and breastfeeding conditions

5. Compounded Formulation Disclosure

All products are pharmacy-compounded formulations prepared on a per-prescription basis.

These formulations are:

* Not mass-manufactured over-the-counter products
* Not individually approved by DRAP or the FDA
* Prepared under prescription-based clinical supervision

6. Patient Responsibilities

Patients must:

* Provide accurate medical history and photographs during consultation
* Follow prescribed dosage, frequency, and instructions strictly
* Avoid self-adjustment or sharing medications with others
* Report any adverse reactions immediately to the treating doctor


7. Risk & Side Effect Acknowledgment

All treatments may carry potential risks depending on individual response. Patients are advised that:

* Outcomes vary based on medical condition and adherence
* Side effects may occur even when used correctly
* Immediate medical consultation is required if adverse reactions develop

8. AI-Assisted Clinical Workflow Disclaimer

The platform uses an AI-supported system to:

* Collect scalp images and structured medical history
* Assist in organizing patient data for dermatological review

However:

* AI does not provide final diagnosis or prescriptions
* Final treatment decisions are exclusively made by licensed doctors

9. Regulatory Compliance Statement

The platform operates under a doctor-led prescription model with structured clinical oversight. Following regulatory expectations of DRAP, we have implemented:

* Mandatory doctor review before dispensing
* Restricted access to prescription-only medications
* Transparent safety disclosures for all active ingredients
* Secure medical record keeping and consultation tracking
* Removal of any non-prescription sale pathways

We remain committed to continuous improvement in patient safety, ethical prescribing, and regulatory compliance.